When subgroup analyses were performed by gender, HBV genotype, serum HBV DNA, ALT, or AST levels, no statistical difference of the G870A distribution was observed among any subgroups of CHB, cirrhotic CHB, and HCC groups (Table S1). The gene discussed is GPT; the disease is hepatocellular carcinoma.